TCR/ITK Signaling in Type 1 Regulatory T cells

Type 1 regulatory T (Tr1) cells can modulate inflammation through multiple direct and indirect molecular and cellular mechanisms and have demonstrated potential for anti-inflammatory therapies. Tr1 cells do not express the master transcription factor of conventional regulatory T cells, Foxp3, but ex...

Full description

Saved in:
Bibliographic Details
Published inAdvances in experimental medicine and biology Vol. 1278; p. 115
Main Authors McGee, Michael C, August, Avery, Huang, Weishan
Format Journal Article
LanguageEnglish
Published United States 01.01.2021
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Type 1 regulatory T (Tr1) cells can modulate inflammation through multiple direct and indirect molecular and cellular mechanisms and have demonstrated potential for anti-inflammatory therapies. Tr1 cells do not express the master transcription factor of conventional regulatory T cells, Foxp3, but express high levels of the immunomodulatory cytokine, IL-10. IL-2-inducible T-cell kinase (ITK) is conserved between mouse and human and is highly expressed in T cells. ITK signaling downstream of the T-cell receptor (TCR) is critical for T-cell subset differentiation and function. Upon activation by TCR, ITK is critical for Ras activation, leading to downstream activation of MAPKs and upregulation of IRF4, which further enable Tr1 cell differentiation and suppressive function. We summarize here the structure, signaling pathway, and function of ITK in T-cell lineage designation, with an emphasis on Tr1 cell development and function.
ISSN:0065-2598
DOI:10.1007/978-981-15-6407-9_7